- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MMNFF
Recent news which mentions MMNFF
Cannabis Dispensary Roundup: MedMen Opens Shop In Florida, Jushi, The Cake House And PA Options For Wellness Each Roll Out Stores
September 09, 2021
From Benzinga
2 Robinhood Stocks With Market-Beating Potential
September 08, 2021
From Motley Fool
Tilray Stock Is a Buy Here, but a Very Frustrating One
August 30, 2021
From InvestorPlace
From Benzinga
Tilray Stock Looks Worse and Worse, and M&A Isn’t Helping
August 26, 2021
From InvestorPlace
Tilray Has a Lot of Potential if the U.S. Legalizes Cannabis
August 25, 2021
From InvestorPlace
From Motley Fool
Pot and poppy paintings: Inside a cannabis lifestyle company’s ‘immersive’ Van Gogh exhibit
August 24, 2021
From MarketWatch
From Benzinga
The Week In Cannabis: PharmaCann Could IPO, Tilray & MedMen, First Black CEO At Major Public Co. And More
August 20, 2021
From Benzinga
Tilray Adjourns Special Meeting Of Stockholders Until Sept. 10
August 19, 2021
From Benzinga
Palantir, Clover Health, Robinhood, Nvidia, AMC And More — Stocks Trending On WallStreetBets Today
August 19, 2021
From Benzinga
Why Tilray Stock Rose Today
August 18, 2021
From Motley Fool
5 Cryptos to Buy Before They Rocket Like MedMen
August 18, 2021
From InvestorPlace
Why Tilray Bears Could Go Up In Smoke If History Repeats
August 18, 2021
From Benzinga
Tilray (TLRY) Stock Price Predictions: How High Can the MedMen Deal Take TLRY Stock?
August 18, 2021
From InvestorPlace
Why Sundial Growers Stock Popped Wednesday Morning
August 18, 2021
From Motley Fool
Analysts upbeat on Tilray’s U.S. prospects after MedMen deal
August 18, 2021
From MarketWatch
TLRY, MMNFF: 9 Things to Know About the Hot Tilray-MedMen Deal
August 18, 2021
From InvestorPlace
From InvestorPlace
Analyst Says MedMen's Momentum Changing, Tilray's Stake Won't Double Its Value But Will Hold Premium
August 18, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021
August 18, 2021
From Benzinga
MedMen Announces $100M Equity Investment On Heels Of Tilray Buying Its Convertible Debt, Deal Led By Serruya Private Equity
August 18, 2021
From Benzinga
Why Tilray Shares Are Trading Higher Today
August 18, 2021
From Benzinga
Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria
August 18, 2021
From Benzinga
From MarketWatch
3 Stocks to Buy Instead of SNDL or TLRY
August 16, 2021
From InvestorPlace
Cannabis Unicorn PharmaCann Could IPO Soon, Valued At $1.1B+
August 16, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.